Salem et al., 2015) (Figure 4)
Phase 2 studies demonstrated that twice-daily exenatide injections significantly lowered blood glucose levels and hemoglobin A1c , with many patients achieving better glycemic control than with oral medications alone ( [58] ) ( [2] )
And for many of our patients, the journey to more energy, better mood, and clearer focus doesnt begin in the brain it starts in the gut
For instance, studies have shown that consumption of broccoli sprouts, which are particularly rich in sulforaphane, can increase cellular glutathione levels
Conclusion GLP-1 receptor agonists are key medications for type 2 diabetes and obesity, working to lower blood sugar and aid weight loss by reducing appetite
[33] [34] In 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) updated its guidance on GLP-1 medication after an increase in reports to the agency's Yellow Card Scheme of acute pancreatitis, with fatalities, in patients taking semaglutide or tirzepatide, to warn of a small risk of developing severe acute pancreatitis